Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,763
archived clinical trials in
Colitis

An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
mi
from
Adelaide,
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
mi
from
Adelaide,
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
A Phase 1, Randomized, Double-blind, Placebo-controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
mi
from
San Diego, CA
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
A Phase 1, Randomized, Double-blind, Placebo-controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
A Phase 1, Randomized, Double-blind, Placebo-controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
mi
from
New Haven, CT
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
A Phase 1, Randomized, Double-blind, Placebo-controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
A Phase 1, Randomized, Double-blind, Placebo-controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
mi
from
Duluth, MN
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
A Phase 1, Randomized, Double-blind, Placebo-controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
mi
from
Duluth, MN
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
A Phase 1, Randomized, Double-blind, Placebo-controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
mi
from
Allentown, PA
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
A Phase 1, Randomized, Double-blind, Placebo-controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
mi
from
Allentown, PA
Click here to add this to my saved trials
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Status: Enrolling
Updated:  6/16/2013
Florida Hospital, Center for Colon & Rectal Surgery
mi
from
Atlamonte Springs, FL
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Status: Enrolling
Updated: 6/16/2013
Florida Hospital, Center for Colon & Rectal Surgery
mi
from
Atlamonte Springs, FL
Click here to add this to my saved trials
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Status: Enrolling
Updated:  6/16/2013
18308 Murdock Circle, Suite 108
mi
from
Port Charlotte, FL
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Status: Enrolling
Updated: 6/16/2013
18308 Murdock Circle, Suite 108
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Status: Enrolling
Updated:  6/16/2013
CoxHealth Hospital, Colorectal Department
mi
from
Springfield, MO
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Status: Enrolling
Updated: 6/16/2013
CoxHealth Hospital, Colorectal Department
mi
from
Springfield, MO
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1055
mi
from
Mobile, AL
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1055
mi
from
Mobile, AL
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1043
mi
from
Anaheim, CA
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1043
mi
from
Anaheim, CA
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1071
mi
from
Lakewood, CA
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1071
mi
from
Lakewood, CA
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1051
mi
from
Los Angeles, CA
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1051
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1003
mi
from
San Diego, CA
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1003
mi
from
San Diego, CA
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1053
mi
from
San Diego, CA
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1053
mi
from
San Diego, CA
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1063
mi
from
Littleton, CO
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1063
mi
from
Littleton, CO
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1028
mi
from
Bristol, CT
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1028
mi
from
Bristol, CT
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1018
mi
from
Hamden, CT
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1018
mi
from
Hamden, CT
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1035
mi
from
Boynton, FL
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1035
mi
from
Boynton, FL
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1045
mi
from
Jacksonville, FL
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1045
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1001
mi
from
Largo, FL
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1001
mi
from
Largo, FL
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1024
mi
from
Maitland, FL
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1024
mi
from
Maitland, FL
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1013
mi
from
Miramar, FL
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1013
mi
from
Miramar, FL
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1009
mi
from
New Smyrna Beach, FL
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1009
mi
from
New Smyrna Beach, FL
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1041
mi
from
Orlando, FL
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1041
mi
from
Orlando, FL
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1029
mi
from
Port Orange, FL
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1029
mi
from
Port Orange, FL
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1010
mi
from
Winter Park, FL
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1010
mi
from
Winter Park, FL
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1002
mi
from
Zephyrhills, FL
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1002
mi
from
Zephyrhills, FL
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1050
mi
from
Decatur, GA
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1050
mi
from
Decatur, GA
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1085
mi
from
Marietta, GA
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1085
mi
from
Marietta, GA
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1075
mi
from
Chicago, IL
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1075
mi
from
Chicago, IL
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1065
mi
from
Oak Lawn, IL
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1065
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1058
mi
from
Indianapolis, IN
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1058
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1008
mi
from
Clive, IA
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1008
mi
from
Clive, IA
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1052
mi
from
Pratt, KA
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1052
mi
from
Pratt, KA
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1034
mi
from
Metairie, LA
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1034
mi
from
Metairie, LA
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1032
mi
from
Shreveport, LA
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1032
mi
from
Shreveport, LA
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1044
mi
from
Annapolis, MD
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1044
mi
from
Annapolis, MD
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1057
mi
from
Chevy Chase, MD
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1057
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1012
mi
from
Hollywood, MD
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1012
mi
from
Hollywood, MD
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1016
mi
from
Chesterfield, MI
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1016
mi
from
Chesterfield, MI
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1081
mi
from
Novi, MI
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1081
mi
from
Novi, MI
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1015
mi
from
Wyoming, MI
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1015
mi
from
Wyoming, MI
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1068
mi
from
Ypsilanti, MI
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1068
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1074
mi
from
Rochester, MN
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1074
mi
from
Rochester, MN
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1049
mi
from
Jackson, MS
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1049
mi
from
Jackson, MS
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1061
mi
from
Lebanon, NH
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1061
mi
from
Lebanon, NH
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1056
mi
from
Marlton, NJ
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1056
mi
from
Marlton, NJ
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1021
mi
from
Cheektowaga, NY
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1021
mi
from
Cheektowaga, NY
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1027
mi
from
Great Neck, NY
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1027
mi
from
Great Neck, NY
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1072
mi
from
Great Neck, NY
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1072
mi
from
Great Neck, NY
Click here to add this to my saved trials